Literature DB >> 23192950

Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited setting.

Peter Hesseling1, Trijn Israels, Mhamed Harif, Guillermo Chantada, Elizabeth Molyneux.   

Abstract

Treatment recommendations for endemic Burkitt lymphoma (BL) in settings with only minimum requirements for curative treatment (PODC setting 1) are described. The reported cure rate for endemic BL is usually <50%. Facilities within setting 1 differ. Three treatment schedules are proposed based on: (1) when accurate staging is not possible, (2) when staging is possible and for (3) relapses and poor responders to primary therapy. A literature review and personal experience were used to formulate the recommendations. Recorded 1-year event free survival was 48% for treatment 1, 61% for treatment 2, and 35% for the rescue treatment.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23192950     DOI: 10.1002/pbc.24407

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  14 in total

1.  Outcome of pediatric non-Hodgkin lymphoma in Central America: A report of the Association of Pediatric Hematology Oncology of Central America (AHOPCA).

Authors:  Armando Peña-Hernandez; Roberta Ortiz; Claudia Garrido; Wendy Gomez-Garcia; Soad Fuentes-Alabi; Roxana Martinez; Monika L Metzger; Guillermo L Chantada; Raul C Ribeiro
Journal:  Pediatr Blood Cancer       Date:  2019-01-24       Impact factor: 3.167

2.  Disruption of HLA class II antigen presentation in Burkitt lymphoma: implication of a 47,000 MW acid labile protein in CD4+ T-cell recognition.

Authors:  Jason M God; Dan Zhao; Christine A Cameron; Shereen Amria; Jennifer R Bethard; Azizul Haque
Journal:  Immunology       Date:  2014-07       Impact factor: 7.397

3.  CYP3A5 genotype and its impact on vincristine pharmacokinetics and development of neuropathy in Kenyan children with cancer.

Authors:  Jodi L Skiles; ChienWei Chiang; Claire H Li; Steve Martin; Ellen L Smith; Gilbert Olbara; David R Jones; Terry A Vik; Saskia Mostert; Floor Abbink; Gertjan J Kaspers; Lang Li; Festus Njuguna; Tammy J Sajdyk; Jamie L Renbarger
Journal:  Pediatr Blood Cancer       Date:  2017-11-08       Impact factor: 3.167

4.  Factors influencing survival among Kenyan children diagnosed with endemic Burkitt lymphoma between 2003 and 2011: A historical cohort study.

Authors:  Geoffrey Buckle; Louise Maranda; Jodi Skiles; John Michael Ong'echa; Joslyn Foley; Mara Epstein; Terry A Vik; Andrew Schroeder; Jennifer Lemberger; Alan Rosmarin; Scot C Remick; Jeffrey A Bailey; John Vulule; Juliana A Otieno; Ann M Moormann
Journal:  Int J Cancer       Date:  2016-05-18       Impact factor: 7.396

Review 5.  Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge.

Authors:  Carlos Rodriguez-Galindo; Paola Friedrich; Patricia Alcasabas; Federico Antillon; Shripad Banavali; Luis Castillo; Trijn Israels; Sima Jeha; Mhammed Harif; Michael J Sullivan; Thuan Chong Quah; Catherine Patte; Ching-Hon Pui; Ronald Barr; Thomas Gross
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

6.  Five decades of low intensity and low survival: adapting intensified regimens to cure pediatric Burkitt lymphoma in Africa.

Authors:  Nmazuo W Ozuah; Joseph Lubega; Carl E Allen; Nader Kim El-Mallawany
Journal:  Blood Adv       Date:  2020-08-25

Review 7.  Antibody therapies for lymphoma in children.

Authors:  Verena de Zwart; Samantha C Gouw; Friederike A G Meyer-Wentrup
Journal:  Cochrane Database Syst Rev       Date:  2016-01-19

8.  Beyond Endemic Burkitt Lymphoma: Navigating Challenges of Differentiating Childhood Lymphoma Diagnoses Amid Limitations in Pathology Resources in Lilongwe, Malawi.

Authors:  Nader Kim El-Mallawany; Mercy Mutai; Idah Mtete; Satish Gopal; Christopher C Stanley; Peter Wasswa; Mary Mtunda; Mary Chasela; William Kamiyango; Jimmy Villiera; Yuri Fedoriw; Nathan D Montgomery; George N Liomba; Coxcilly Kampani; Robert Krysiak; Katherine D Westmoreland; Maria H Kim; Jeremy S Slone; Michael E Scheurer; Carl E Allen; Parth S Mehta; Peter N Kazembe
Journal:  Glob Pediatr Health       Date:  2017-06-23

9.  An unusual abdominal wall mass in a child.

Authors:  Amalia Maria do Espirito Santo Souza; Tomas Marzagão Barbuto; Flávia Alessandra Freitas; Nathalia Fernandes Vianna; Carla Maria Costa Zanchetta; Silvana Forsait; Claudio Borba; Alessandra Milani Prandini de Azambuja; Lilian Maria Cristofani; Vicente Odone
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2017-04-13       Impact factor: 1.846

10.  The COVID-19 pandemic: A rapid global response for children with cancer from SIOP, COG, SIOP-E, SIOP-PODC, IPSO, PROS, CCI, and St Jude Global.

Authors:  Michael Sullivan; Eric Bouffet; Carlos Rodriguez-Galindo; Sandra Luna-Fineman; Muhammad Saghir Khan; Pam Kearns; Douglas S Hawkins; Julia Challinor; Lisa Morrissey; Jörg Fuchs; Karen Marcus; Adriana Balduzzi; Luisa Basset-Salom; Miguela Caniza; Justin N Baker; Rejin Kebudi; Laila Hessissen; Richard Sullivan; Kathy Pritchard-Jones
Journal:  Pediatr Blood Cancer       Date:  2020-05-13       Impact factor: 3.838

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.